SC Nutrilife SRL
Bucuresti, Romania
Sos. Bucuresti-Ploiesti, 17, Bucuresti-Sector 1, Bucuresti, 013682, București
About SC Nutrilife SRL
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Eli Lilly and Company
7
Clinical Trials at SC Nutrilife SRL
During the past decade, SC Nutrilife SRL conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 3 clinical trials were completed, i.e. on
average, 42.9% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 3 clinical trials were completed. i.e. 75%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of the Efficacy and Safety of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes
2018-04-05
2019-10-10
Completed
1,842
A Study of Tirzepatide (LY3298176) Once a Week Versus Insulin Glargine Once a Day in Participants With Type 2 Diabetes and Increased Cardiovascular Risk
2018-11-20
2021-04-22
Completed
2,002
A Study of Tirzepatide (LY3298176) Versus Insulin Degludec in Participants With Type 2 Diabetes
2019-04-01
2021-01-04
Completed
1,444
A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes
2020-05-29
2024-10-17
Active, not recruiting
13,299
A Study of Tirzepatide (LY3298176) Versus Insulin Lispro (U100) in Participants With Type 2 Diabetes Inadequately Controlled on Insulin Glargine (U100) With or Without Metformin
2020-10-19
2022-11-01
Completed
1,428
A Study of Tirzepatide Compared With Intensified Conventional Care in Adult Participants With Type 2 Diabetes
2022-08-01
2027-06-07
Recruiting
780
A Study of Tirzepatide (LY3298176) on the Reduction on Morbidity and Mortality in Adults With Obesity
2022-10-11
2027-10-07
Recruiting
15,000
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at SC Nutrilife SRL
According to Clinical.Site data, the most researched conditions in "SC Nutrilife SRL" are
"Type 2 Diabetes Mellitus" (3 trials), "Type 2 Diabetes" (2 trials), "Diabetes Mellitus, Type 2" (1 trials), "Obesity" (1 trials) and "Overweight" (1 trials). Many other conditions were trialed in "SC Nutrilife SRL" in a lesser frequency.
Clinical Trials Intervention Types at SC Nutrilife SRL
Most popular intervention types in "SC Nutrilife SRL" are "Drug" (7 trials). Other intervention types were less common.
The name of intervention was led by "Tirzepatide" (6 trials), "Dulaglutide" (2 trials), "Antihyperglycemic medication" (1 trials), "Insulin Degludec" (1 trials) and "Insulin Glargine" (1 trials). Other intervention names were less common.
Clinical Trials Genders at SC Nutrilife SRL
The vast majority of trials in "SC Nutrilife SRL" are
7 trials for "All" genders.
Clinical Trials Status at SC Nutrilife SRL
Currently, there are NaN active trials in "SC Nutrilife SRL".
undefined are not yet recruiting,
2 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 4 completed trials in SC Nutrilife SRL,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in SC Nutrilife SRL, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 6 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".